Marvel Biosciences Corp (MRVL) — Net Asset Quality Index
Marvel Biosciences Corp (MRVL) has a Net Asset Quality Index of -534.6% as of October 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CA$683.06K minus total liabilities of CA$4.33 Million yields net assets of CA$-3.65 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore MRVL asset base for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
Marvel Biosciences Corp Net Asset Quality Index Over Time (2020–2025)
This chart shows how Marvel Biosciences Corp's Net Asset Quality Index has evolved across 6 annual periods from 2020 to 2025. As of October 2025, the index stands at -534.6%, representing net assets of CA$-3.65 Million against total assets of CA$683.06K CAD. See MRVL working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Marvel Biosciences Corp (2020–2025)
The table below presents the year-by-year Net Asset Quality Index for Marvel Biosciences Corp from 2020 to 2025, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Marvel Biosciences Corp market cap and net worth.
| Year | Quality Index | Net Assets (CAD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -1226.2% | CA$-4.01 Million | CA$326.71K | CA$4.33 Million | ▼ -651.1 pp |
| 2024 | -575.2% | CA$-2.83 Million | CA$491.31K | CA$3.32 Million | ▼ -319.3 pp |
| 2023 | -255.8% | CA$-1.72 Million | CA$672.39K | CA$2.39 Million | ▼ -277.2 pp |
| 2022 | 21.4% | CA$195.54K | CA$913.54K | CA$718.00K | ▼ -74.0 pp |
| 2021 | 95.4% | CA$2.36 Million | CA$2.47 Million | CA$112.48K | ▲ +55.3 pp |
| 2020 | 40.1% | CA$118.80K | CA$295.99K | CA$177.18K | — |